Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients
暂无分享,去创建一个
P. Russell | D. Liew | S. Knight | R. Wynne | M. Conron | T. John | Gavin Wright | Z. Wainer | M. Walkiewicz | J. Gooi | S. Barnett